Cite
Hu X, Liu X, Moisan J, et al. Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology. 2016;5(12):e1254854doi: 10.1080/2162402X.2016.1254854.
Hu, X., Liu, X., Moisan, J., Wang, Y., Lesch, C. A., Spooner, C., Morgan, R. W., Zawidzka, E. M., Mertz, D., Bousley, D., Majchrzak, K., Kryczek, I., Taylor, C., Van Huis, C., Skalitzky, D., Hurd, A., Aicher, T. D., Toogood, P. L., Glick, G. D., Paulos, C. M., Zou, W., & Carter, L. L. (2016). Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology, 5(12), e1254854. https://doi.org/10.1080/2162402X.2016.1254854
Hu, Xiao, et al. "Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity." Oncoimmunology vol. 5,12 (2016): e1254854. doi: https://doi.org/10.1080/2162402X.2016.1254854
Hu X, Liu X, Moisan J, Wang Y, Lesch CA, Spooner C, Morgan RW, Zawidzka EM, Mertz D, Bousley D, Majchrzak K, Kryczek I, Taylor C, Van Huis C, Skalitzky D, Hurd A, Aicher TD, Toogood PL, Glick GD, Paulos CM, Zou W, Carter LL. Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology. 2016 Nov 04;5(12):e1254854. doi: 10.1080/2162402X.2016.1254854. eCollection 2016. PMID: 28123897; PMCID: PMC5215247.
Copy
Download .nbib